Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3023919	s-ld-2	% (%)	177	184	0.54%
3023919	s-ld-2	— (—)	15	16	100.00%	Distribution not available
3023919	s-laktaattidehydrogenaasi2(s-ld-is)	% (%)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Melanoma of uvea

+∞

14.69

1.1

0.0

35.56

—

Melanoma of uvea

+∞

14.69

1.1

0.0

35.56

—

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

+∞

14.64

1.1

0.0

35.56

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

124

3.30

14.16

1.1

1.0

36.15

36.18

0.01

117

Neoplasms

3.38

8.07

1.1

36.35

34.37

1.24

All pneumoniae

135

2.51

7.64

1.0

1.1

36.31

35.88

0.21

126

Oral corticosteroids

122

2.48

7.39

1.1

36.40

35.69

0.48

114

Influenza and pneumonia

134

2.40

6.97

1.0

1.1

36.40

35.92

0.24

125

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

112

2.52

6.94

1.0

1.1

36.46

35.89

0.26

103

112

2.52

6.94

1.0

1.1

36.45

35.89

0.26

103

Pneumonia, organism unspecified

129

2.47

6.78

1.0

1.1

36.73

36.07

0.33

120

Pneumonias (Asthma/COPD co-morbidities)

136

2.39

6.73

1.0

1.1

36.26

35.83

0.20

127

GASTRO-related operations

2.87

6.57

1.1

1.0

35.45

36.36

0.41

Any gastric operation

2.87

6.57

1.1

1.0

35.45

36.36

0.41

Non-invasive ventilation

4.88

6.38

1.1

36.43

35.27

0.26

Malignant neoplasm of eye and adnexa

+∞

6.27

1.3

0.0

36.02

—

Other autoimmune haemolytic anaemias

+∞

6.26

1.0

0.0

31.97

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

139

2.33

6.24

1.0

1.1

36.44

35.92

0.25

130

Other bacterial diseases

133

2.29

5.76

1.0

1.1

37.48

35.79

1.25

127

Non-allergic asthma (mode), excluding more controls

5.51

5.25

1.0

1.2

37.11

35.21

—

Diseases of the digestive system

2.85

4.88

1.1

35.59

36.86

0.51

Benign neoplasms

2.65

4.87

1.1

1.0

37.29

34.63

2.42

Venous thromboembolism

2.56

4.52

1.1

37.69

36.46

0.91

DVT of lower extremities and pulmonary embolism

2.87

4.29

1.1

37.51

36.50

0.64

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

2.81

3.72

1.0

1.1

36.28

36.14

0.05

Pulmonary heart disease, diseases of pulmonary circulation

2.83

3.35

1.0

1.1

37.53

36.99

0.29

Dialysis, with operation codes

4.74

3.23

1.0

1.1

35.88

36.44

—

Disorders resulting from impaired renal tubular function

10.03

2.98

1.2

1.0

38.92

40.08

—

Hypothyroidism and >3 levothyroxin purchases

3.84

2.96

1.3

1.0

35.79

35.25

—

Hypothyroidism, levothyroxine purchases

3.84

2.96

1.3

1.0

35.79

35.25

—

Hypothyroidism (congenital or acquired)

3.83

2.95

1.3

1.0

35.79

35.25

—

Injuries to unspecified part of trunk, limb or body region

4.45

2.79

1.0

1.1

36.16

37.37

—

Hypothyroidism, drug reimbursement

4.77

2.78

1.4

1.0

37.60

35.14

—

Endocrine, nutritional and metabolic diseases

1.95

2.69

1.1

1.0

36.70

36.05

0.38

Colorectal cancer, excluding all cancers (controls excluding all cancers)

2.96

2.64

1.0

1.1

36.37

36.61

0.07

Other infectious diseases

4.67

2.59

1.0

1.1

38.10

37.04

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.11

2.58

1.0

1.1

30.12

36.90

1.68

Other symptoms and signs involving the circulatory and respiratory systems

5.46

2.54

1.2

1.1

35.15

37.34

—

Infections, IBD-co-morbidities

4.16

2.52

1.0

38.32

36.61

—

Hypoglycaemia, other or unspecified

5.01

2.40

1.2

1.1

36.68

37.50

—

Tubulo-interstitial nephritis, not specified as acute or chronic

6.26

2.37

1.0

34.90

38.80

—

Somatoform disorder

3.64

2.36

1.0

1.1

37.50

36.73

—

Disorders of choroid and retina

121

1.81

2.31

1.0

1.1

36.08

36.57

0.23

110

Other retinal disorders

100

1.93

2.29

1.0

1.1

36.33

36.87

0.21

Ulcerative rectosigmoiditis

4.62

2.27

1.0

1.1

36.83

36.07

—

Benign neoplasms

113

1.73

2.23

1.1

1.0

37.17

35.59

1.53

103

Cirrhosis of liver, NAS

5.57

2.21

1.0

1.1

34.98

38.42

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.56

2.21

1.0

36.26

36.02

—

Vocal cord dysfunction

3.83

2.20

1.1

36.23

35.70

—

Divergent concomitant strabismus

4.29

2.15

1.0

1.1

34.52

37.44

—

Other disorders of glucose regulation and pancreatic internal secretion

4.29

2.15

1.2

1.1

36.68

37.89

—

L04AD Calcineurin inhibitors

3.69

2.15

1.0

1.1

36.11

35.75

—

Other obstetric conditions, not elsewhere classified

2.75

2.15

1.0

1.1

30.12

36.68

1.63

Convulsions, not elsewhere classified

3.29

2.15

1.0

1.1

33.27

37.06

—

Glaucoma suspect

2.30

2.14

1.3

1.0

37.81

36.14

0.80

Osteomyelitis

5.01

2.07

1.2

1.1

38.94

39.05

—

Diarrhoea and gastroenteritis of presumed infectious origin

119

1.83

2.04

1.0

1.1

36.06

36.46

0.13

113

All influenza

2.63

2.00

1.0

1.1

35.86

37.29

—

Heart failure and antihypertensive medication

2.75

1.97

1.0

36.33

37.30

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2.20

1.95

1.0

1.1

37.14

36.10

0.35

Valvular operations

3.75

1.93

1.0

1.1

36.52

37.68

—

Use of memantine

0.00

1.88

0.0

1.0

—

37.90

—

Use of other anti-dementia drugs

0.00

1.88

0.0

1.0

—

37.90

—

Foreign body on external eye

3.18

1.88

1.0

1.1

36.60

36.77

—

Injuries to the head

156

1.59

1.87

1.1

36.22

36.00

0.12

147

Soft tissue disorders

120

1.60

1.81

1.1

1.0

36.90

35.68

0.82

109

Rheumatoid arthritis, including avohilmo

2.06

1.80

1.1

38.20

36.17

1.38

Adverse effects, not elsewhere classified

3.05

1.79

1.3

1.0

37.90

36.97

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2.11

1.78

1.0

1.1

37.18

36.07

0.39

Injury of unspecified body region

3.85

1.71

1.0

37.74

37.32

—

Poor fetal growth

3.85

1.71

1.0

1.1

29.40

34.56

—

Sicca syndrome [Sjögren]

3.58

1.61

1.2

1.0

36.66

37.50

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

3.57

1.61

1.0

36.70

36.91

—

Methotrexate

3.00

1.58

1.0

1.1

37.47

36.47

—

Deviated nasal septum

2.10

1.54

1.1

35.55

36.07

0.21

L04AA Selective immunosuppressants

2.43

1.53

1.0

1.1

38.13

36.43

—

Genitourinary diseases

1.78

1.51

1.1

1.0

35.97

36.34

0.12

Viral pneumonia

2.86

1.50

1.0

36.58

36.63

—

Congenital malformations, deformations and chromosomal abnormalities

104

1.75

1.47

1.1

35.66

36.16

0.13

Myeloproliferative diseases (CML excluded)

3.13

1.44

1.2

1.0

39.94

38.37

—

Direct fill therapy

2.73

1.43

1.0

36.13

36.30

—

Endometriosis of pelvic peritoneum

2.69

1.41

1.2

1.0

34.28

35.65

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

2.41

1.39

1.0

1.1

36.40

36.27

—

Malignant neoplasm of digestive organs

1.94

1.37

1.0

1.1

35.82

37.57

0.86

Candidiasis

2.61

1.36

1.0

36.10

36.93

—

Other and unspecified visual disturbances

2.94

1.36

1.0

1.1

36.68

36.71

—

Melanocytic naevi of trunk

2.94

1.36

1.0

1.1

37.56

36.41

—

Appendectomy

116

1.66

1.31

1.1

35.84

36.19

0.09

110

Chronic periodontitis, complicated

2.78

1.28

1.0

1.1

36.54

37.39

—

Achilles tendinitis

2.78

1.28

1.2

39.72

37.53

—

Tinnitus

2.29

1.26

1.4

1.1

34.06

37.34

—

Degeneration of macula and posterior pole

1.76

1.25

1.0

1.1

36.09

37.28

0.39

In situ neoplasms

2.07

1.25

1.0

1.1

36.29

36.50

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.42

1.25

1.0

38.93

36.75

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.01

1.21

1.1

1.0

35.91

36.13

0.05

Endometriosis ASRM stages 1,2

2.31

1.18

1.2

1.1

34.28

35.79

—

Congenital malformations of heart and great arteries

2.55

1.17

1.0

1.1

38.64

37.03

—

Fracture of lower leg, including ankle

112

0.44

1.12

1.0

1.1

37.16

36.52

—

105

Codeine

112

1.47

1.12

1.1

36.46

35.85

0.31

106

Other soft tissue disorders, not elsewhere classified

117

1.48

1.10

1.0

36.14

35.70

0.22

106

Abnormal involuntary movements

2.38

1.09

1.0

38.48

37.17

—

Congenital malformations of the circulatory system

2.31

1.05

1.0

39.64

36.41

—

Chalazion

2.27

1.03

1.0

34.28

36.81

—

Cardiomyopathy

2.27

1.03

1.2

1.0

35.96

38.14

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1.75

0.99

1.0

1.1

36.24

36.34

0.03

Other special examinations and investigations of persons without complaint or reported diagnosis

1.53

0.97

1.1

1.0

35.14

36.12

0.42

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

0.51

0.95

1.2

1.1

32.90

36.25

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.95

0.0

1.1

—

37.09

—

Other benign neoplasms of skin

1.77

0.94

1.1

37.21

36.40

—

TMD related operations

2.22

0.93

1.0

1.1

35.48

36.30

—

Lumbar disc prolapse

113

1.48

0.89

1.0

1.1

35.84

35.46

0.15

104

Retention of urine

1.72

0.84

1.0

1.1

37.36

36.83

0.13

Hernia of abdominal wall

1.63

0.84

1.1

35.15

36.66

0.51

Aortic aneurysm

1.75

0.82

1.0

1.1

38.14

37.09

—

Single delivery by forceps and vacuum extractor

0.00

0.81

0.0

1.1

—

35.83

—

Chondropathies

0.00

0.79

0.0

1.0

—

36.62

—

Retinal detachments and breaks

1.67

0.78

1.0

1.1

37.95

36.91

0.39

Gout, FINNGEN

1.70

0.75

1.2

1.0

37.23

37.18

—

Neurological diseases, wide definition

1.85

0.74

1.0

35.37

35.46

—

Continuous positive airway pressure

2.05

0.74

1.2

1.0

36.70

35.66

—

Exclusions for E4_PCOS_BROAD

2.00

0.72

1.0

36.32

36.61

—

Fibroblastic disorders

1.80

0.72

1.3

1.1

35.57

36.65

—

Gestational [pregnancy-induced] hypertension

1.79

0.72

1.1

33.54

36.18

—

Acute upper respiratory infections

147

1.32

0.72

1.1

35.89

36.40

0.29

135

Acute upper respiratory infections of multiple and unspecified sites

112

1.40

0.71

1.0

1.1

34.57

36.32

0.74

104

Superficial injury of wrist and hand

1.92

0.70

1.0

38.88

36.55

—

Constipation

138

1.35

0.70

1.0

1.1

36.06

36.24

0.08

131

Allergic asthma (mode), excluding more controls

1.89

0.69

1.0

1.1

36.50

35.65

—

Diverticular disease of intestine

100

1.39

0.68

1.1

36.98

36.81

0.06

Fracture of shoulder and upper arm

1.52

0.68

1.0

1.1

37.04

36.80

—

Codeine or tramadol medication

146

1.29

0.66

1.1

36.15

35.96

0.09

138

Maternal care for known or suspected malpresentation of fetus

1.78

0.65

1.0

35.38

35.45

—

Allergic asthma (mode)

1.69

0.62

1.0

1.1

36.50

35.73

—

Sudden idiopathic hearing loss

0.00

0.60

0.0

1.1

—

37.78

—

Multiple delivery

0.00

0.60

0.0

1.1

—

36.52

—

1.54

0.59

1.0

37.00

37.46

—

Rosacea

0.00

0.59

0.0

1.0

—

37.13

—

Puerperal sepsis

0.00

0.59

0.0

1.1

—

36.27

—

Malignant neoplasm of prostate

0.56

0.58

1.0

1.1

36.90

36.94

—

Diseases of inner ear

104

1.41

0.56

1.0

1.1

37.12

36.84

0.10

Alcohol use disorder, Swedish definition

1.41

0.55

1.0

1.1

35.92

36.38

0.15

In situ neoplasms

1.54

0.55

1.0

1.1

36.29

36.31

—

Disorders of vestibular function (Vertigo)

1.43

0.53

1.0

1.1

37.58

36.72

0.32

Other arthrosis

1.39

0.51

1.1

1.0

36.52

36.16

0.11

Cutaneous abscess, furuncle and carbuncle

1.46

0.50

1.2

1.1

36.35

36.65

—

Pain in limb

112

1.29

0.45

1.1

1.0

36.47

35.71

0.44

101

Persons encountering health services for examination and investigation

1.30

0.43

1.2

1.0

35.93

36.12

0.05

Speech disturbances, not elsewhere classified

0.00

0.41

0.0

1.0

—

38.44

—

Twin gestation

0.00

0.41

0.0

1.1

—

36.78

—

Multiple gestation

0.00

0.41

0.0

1.1

—

36.78

—

Postpartum haemorrhage due to retained placenta

0.00

0.41

0.0

1.1

—

34.99

—

Nummular dermatitis

0.00

0.41

0.0

1.0

—

37.50

—

Other appendicitis

0.00

0.41

0.0

1.1

—

36.13

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.41

0.0

1.1

—

37.27

—

Injury of muscle and tendon at hip and thigh level

0.00

0.41

0.0

1.1

—

36.51

—

Deep bite

0.00

0.41

0.0

1.1

—

36.32

—

Presence of other functional implants

1.33

0.41

1.0

1.1

35.95

36.44

0.20

Benign neoplasm: Adrenal gland

0.00

0.40

0.0

1.1

—

38.00

—

Dental caries 2, only avohilmo

118

1.27

0.39

1.0

1.1

35.01

36.45

0.50

111

Other and unspecified rosacea

0.00

0.39

0.0

1.1

—

36.66

—

Atrial fibrillation and flutter with reimbursement

1.48

0.36

1.0

36.73

37.53

—

Dental caries 2

119

1.25

0.36

1.0

1.1

35.01

36.38

0.47

112

Other benign neoplasms of skin

1.27

0.36

1.1

37.21

36.60

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1.36

0.34

1.0

1.1

36.88

36.45

—

Atrial fibrillation and flutter

1.38

0.32

1.0

36.13

36.81

—

110

1.25

0.30

1.0

1.1

34.53

36.45

0.58

101

Acute sinusitis

1.28

0.29

1.2

1.1

36.40

36.46

0.03

Dental caries 2 and operation codes

117

1.22

0.29

1.0

1.1

34.90

36.43

0.51

110

116

1.24

0.29

1.0

1.1

34.79

36.42

0.50

106

Injuries to the shoulder and upper arm

155

1.19

0.28

1.0

1.1

36.73

36.09

0.25

143

Hernia

145

1.17

0.27

1.0

1.1

37.14

36.04

0.69

134

Polycystic ovarian syndrome, consortium definition

0.80

0.26

1.2

1.1

35.67

35.59

0.02

Pregnancy hypertension

1.20

0.26

1.1

33.67

36.22

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.74

0.25

1.3

1.1

32.50

35.97

—

Maternal care for other known or suspected fetal problems

1.34

0.23

1.0

1.1

26.36

35.30

—

Mental and behavioural disorders due to alcohol

1.24

0.23

1.0

1.1

34.42

36.58

0.51

Specific personality disorders

1.32

0.23

1.4

1.1

37.86

35.75

—

Complications following abortion and ectopic and molar pregnancy

0.00

0.21

0.0

1.0

—

36.46

—

Maternal care for cervical incompetence

0.00

0.21

0.0

1.0

—

35.93

—

Lesion of lateral popliteal nerve

0.00

0.21

0.0

1.1

—

37.62

—

Chronic iridocyclitis

0.00

0.21

0.0

1.0

—

37.46

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.21

0.0

1.0

—

36.85

—

Glaucoma-related operations

0.00

0.21

0.0

1.0

—

38.61

—

Other neurotic disorders

0.00

0.21

0.0

1.1

—

37.22

—

Sequelae of other external causes

0.00

0.21

0.0

1.0

—

37.37

—

Foreign body in alimentary tract

0.00

0.21

0.0

1.1

—

37.14

—

Injury of other and unspecified intrathoracic organs

0.00

0.21

0.0

1.1

—

38.46

—

Inflammatory disorders of breast

0.00

0.21

0.0

1.0

—

35.31

—

Other diseases of jaws

0.00

0.21

0.0

1.1

—

36.45

—

Other osteochondropathies

0.00

0.21

0.0

1.1

—

35.99

—

Stomatitis and related lesions

0.00

0.21

0.0

1.1

—

36.45

—

Abnormal findings on antenatal screening of mother

0.00

0.21

0.0

1.1

—

33.50

—

Alzheimer’s disease (Early onset), excluding more controls

0.00

0.21

0.0

1.1

—

36.91

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

0.00

0.21

0.0

1.0

—

37.83

—

Atypical facial pain

0.00

0.21

0.0

1.0

—

38.18

—

Oral lichen ruber planus, including avohilmo

0.00

0.21

0.0

1.0

—

37.92

—

Hordeolum and other deep inflammation of eyelid

0.00

0.21

0.0

1.0

—

37.00

—

Other orthopaedic follow-up care

0.00

0.21

0.0

1.0

—

36.52

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.21

0.0

1.1

—

38.07

—

Other otitis externa (chronic)

0.00

0.21

0.0

1.1

—

37.44

—

Amputation of toe

0.00

0.21

0.0

1.1

—

38.58

—

LSIL lesion of the cervix uteri

0.00

0.21

0.0

1.1

—

34.23

—

Bullous disorders

0.00

0.21

0.0

1.0

—

37.32

—

Thyrotoxicosis with toxic multinodular goitre

0.00

0.21

0.0

1.0

—

38.00

—

Trigeminal neuralgia

0.00

0.21

0.0

1.0

—

38.59

—

Other disorders of nervous system

0.00

0.21

0.0

1.1

—

38.42

—

Other coagulation defects

0.00

0.21

0.0

1.1

—

36.94

—

Excessive vomiting in pregnancy

0.00

0.21

0.0

1.1

—

34.57

—

Bronchitis, not specified as acute or chronic

0.00

0.21

0.0

1.1

—

36.64

—

Disorders of vitreous body and globe

1.22

0.20

1.1

37.53

36.37

0.53

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.26

0.20

1.0

1.1

38.42

35.70

—

Pedestrian injured in transport accident

0.00

0.20

0.0

1.1

—

36.42

—

Disorders of adult personality and behaviour

1.25

0.20

1.3

1.1

37.27

35.92

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.20

0.0

1.1

—

35.01

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.22

0.20

1.2

1.1

36.08

36.68

—

Other enthesopathies

1.20

0.19

1.0

1.1

32.67

36.22

—

Pre-eclampsia or poor fetal growth

1.17

0.19

1.0

1.1

30.30

36.30

—

Disorders of skin appendages

1.21

0.17

1.1

36.69

36.25

0.18

Obesity

118

1.17

0.17

1.2

1.1

37.16

36.04

0.49

110

Abnormal serum enzyme levels

1.11

0.17

1.0

1.1

36.21

36.67

—

Inguinal hernia

1.16

0.16

1.1

1.0

36.06

36.62

0.22

Obesity and other hyperalimentation

119

1.16

0.16

1.2

1.1

37.16

36.01

0.50

111

Alcohol use disorder, ICD-based

1.15

0.15

1.0

1.1

36.02

36.48

—

Dental caries 3 and operation codes, only avohilmo

0.80

0.15

1.0

36.67

36.49

—

Other and unspecified disorders of vitreous body

1.12

0.15

1.0

1.1

37.06

36.51

—

malignant neoplasm of male genital organs

0.79

0.15

1.0

1.1

36.06

36.94

—

Disorders of vitreous body

1.17

0.13

1.1

37.45

36.46

0.39

Umbilical hernia

1.11

0.09

1.0

1.1

37.42

37.35

—

Dental caries 1 and operation codes, only avohilmo

1.03

0.08

1.0

36.91

37.08

—

Injury of muscle and tendon at shoulder and upper arm level

1.04

0.08

1.0

1.1

35.77

36.73

—

Recurrent or chronic depression

0.83

0.08

1.0

36.18

35.95

—

COPD, hospital admissions 1, only main diagnosis

1.05

0.07

1.0

1.1

38.11

37.12

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.05

0.07

1.0

1.1

36.02

36.31

—

Dental caries 2 and operation codes, only avohilmo

104

1.07

0.05

1.0

34.90

36.09

0.37

Other symptoms and signs involving cognitive functions and awareness

1.10

0.04

1.0

1.1

35.56

37.16

—

Dislocation, sprain and strain of joints and ligaments of knee

121

1.07

0.04

1.1

33.89

36.01

0.68

115

Spondylopathies

109

1.06

0.04

1.1

36.01

35.77

0.08

100

Coxarthrosis [arthrosis of hip](FG)

0.97

0.00

1.1

1.0

36.09

36.10

0.00

Coxarthrosis

0.97

0.00

1.1

1.0

36.24

36.66

—

Other specified/unspecified dorsopathies

0.00

0.0

1.0

—

37.14

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

0.0

1.0

—

37.48

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.00

0.0

1.0

—

38.32

—

Other and unspecified disease of Bartholin gland

0.00

0.0

1.0

—

37.23

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

0.0

1.0

—

38.86

—

Other and unspecified abdominal hernia

0.00

0.0

1.1

—

38.83

—

Prepatellar bursitis

0.00

0.0

1.0

—

38.92

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

0.0

1.0

—

38.99

—

Gonococcal infection

0.00

0.0

1.0

—

36.04

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

0.86

0.00

1.0

1.1

36.17

37.03

—

Pustular psoriasis

0.00

0.0

1.0

—

37.58

—

Hypertrophic scar

0.00

0.0

1.0

—

35.97

—

Somnolence, stupor and coma

0.00

0.0

1.0

—

37.17

—

Diffuse brain injury

0.00

0.0

1.1

—

36.00

—

MS-disease / Multiple Sclerosis

0.00

0.0

1.0

—

34.52

—

Recurring oral aphthae

0.00

0.0

1.0

—

36.02

—

Scar conditions and fibrosis of skin

0.00

0.0

1.0

—

34.54

—

Hypertrophic disorders of skin

0.00

0.0

1.0

—

35.97

—

Systemic atrophies primarily affecting the central nervous system

0.00

0.0

1.0

—

39.15

—

Other and unspecified erythematous conditions

0.00

0.0

1.0

—

38.32

—

Other and unspecified coagulation defects

0.00

0.0

1.0

—

36.69

—

Granulomatous disorders of skin and subcutaneous tissue

0.00

0.0

1.0

—

38.20

—

Other specified/unspecified spondylopathies

0.00

0.0

1.0

—

40.22

—

Other erythematous conditions

0.00

0.0

1.0

—

38.27

—

Intestinal malabsorption

0.00

0.0

1.0

—

36.10

—

Other and unspecified mononeuropathies of upper limb

0.00

0.0

1.0

—

37.22

—

Tobacco use

0.00

0.0

1.0

—

36.02

—

Follow-up examination after treatment for conditions other than malignant neoplasms

0.95

0.00

1.0

35.19

36.30

—

Other and unspecified iridocyclitis

0.00

0.0

1.0

—

37.43

—

Other other unspecified disorders of the circulatory system

0.00

0.0

1.0

—

38.57

—

Cluster headache, wide,, including avohilmo

0.00

0.0

1.0

—

34.54

—

Spinal instabilities

0.00

0.0

1.0

—

37.82

—

Residual foreign body in soft tissue

0.00

0.0

1.0

—

36.76

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.0

1.1

—

37.81

—

Cluster headache, wide

0.00

0.0

1.0

—

35.45

—

Other diseases of peritoneum

0.00

0.0

1.0

—

37.52

—

Immunodeficiencies

0.00

0.0

1.0

—

38.41

—

Carcinoma in situ of other and unspecified sites

0.00

0.0

1.0

—

39.68

—

Personal history of malignant neoplasm

0.00

0.0

1.0

—

37.74

—

Muscle strain

0.00

0.0

1.0

—

35.04

—

Chondrocostal junction syndrome [Tietze]

0.00

0.0

1.0

—

35.19

—

Occupational exposure to risk-factors

0.00

0.0

1.0

—

40.46

—

TMD related pain

0.00

0.0

1.0

—

34.12

—

Follow-up care involving plastic surgery

0.00

0.0

1.0

—

36.47

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.0

1.1

—

35.74

—

Subacute thyroiditis

0.00

0.0

1.0

—

37.43

—

Extreme obesity with alveolar hypoventilation

0.00

0.0

1.1

—

37.82

—

Benign neoplasm of other and unspecified sites

0.00

0.0

1.0

—

38.20

—

Hyperkinetic disorders, excluding more controls

0.00

0.0

1.0

—

34.62

—

Maternal care for known or suspected disproportion

0.00

0.0

1.2

—

35.65

—

Intermittent heterotropia

0.00

0.0

1.0

—

35.88

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.0

1.0

—

34.16

—

Calculus of kidney and ureter

0.89

0.00

1.0

1.1

37.24

36.82

—

Contact with heat and hot substances

0.00

0.0

1.0

—

37.02

—

Other vitreous opacities

0.00

0.0

1.0

—

38.17

—

Renal cell carcinoma of kidney

0.00

0.0

1.0

—

39.38

—

Other and unspecified follicular disorders

0.00

0.0

1.0

—

36.52

—

Meralgia paraesthetica

0.00

0.0

1.0

—

38.14

—

Other and unspecified mononeuropathies, also in other diseases

0.00

0.0

1.0

—

38.67

—

Embolic stroke

0.00

0.0

1.0

—

38.58

—

Nontoxic diffuse goitre

0.00

0.0

1.0

—

37.30

—

Status epilepticus

0.00

0.0

1.1

—

38.43

—

Cholera

0.00

0.0

1.0

—

36.18

—

Dislocation, sprain and strain of joint and ligaments of hip

0.00

0.0

1.0

—

38.44

—

Benign neoplasm: Cranial nerves

0.00

0.0

1.0

—

38.32

—

Noise effects on inner ear

0.00

0.0

1.1

—

38.96

—

Ulcerative proctitis

0.00

0.0

1.1

—

35.77

—

Radial styloid tenosynovitis [de Quervain]

0.00

0.0

1.0

—

35.26

—

Acute gastritis

0.00

0.0

1.0

—

38.04

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

0.00

0.0

1.0

—

39.44

—

Fracture of neck

0.00

0.0

1.0

—

38.50

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

0.0

1.0

—

39.24

—

Contusion of ankle

0.00

0.0

1.0

—

35.88

—

Toxic effect of contact with venomous animals

0.00

0.0

1.0

—

36.23

—

Cervical disc disorders

0.93

0.00

1.0

1.1

38.70

36.34

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

38.66

—

Diaphragmatic hernia

0.87

0.00

1.0

1.1

38.93

36.46

—

Unspecified chronic bronchitis

0.00

0.0

1.2

—

38.28

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.0

1.0

—

39.02

—

Vascular diseases of the intestine

0.00

0.0

1.0

—

39.68

—

Other abnormal findings of blood chemistry

0.00

0.0

1.0

—

38.97

—

L04AC Interleukin inhibitors

0.00

0.0

1.0

—

35.98

—

Serous carcinoma of ovary

0.00

0.0

1.0

—

37.46

—

Use of ropinirole

0.00

0.0

1.0

—

39.25

—

Other facial nerve disorders

0.00

0.0

1.0

—

38.61

—

Use of biperiden

0.00

0.0

1.1

—

36.47

—

Cysts of oral region, not elsewhere classified

0.00

0.0

1.1

—

36.99

—

Ovarian dysfunction

0.00

0.0

1.0

—

32.82

—

Ulcer of vagina/vulva

0.00

0.0

1.0

—

34.54

—

Hypermobility syndrome

0.00

0.0

1.0

—

34.54

—

LeFortI or BSSRO operation

0.00

0.0

1.0

—

33.46

—

Hypoparathyroidism

0.00

0.0

1.0

—

37.89

—

Urolithiasis

0.98

0.00

1.0

1.1

37.90

36.81

—

Medial epicondylitis

0.00

0.0

1.0

—

36.73

—

Hepatic failure, not elsewhere classified

0.00

0.0

1.0

—

39.05

—

Alzheimer’s disease (Early onset)

0.00

0.0

1.0

—

36.85

—

Short Achilles tendon (acquired)

0.00

0.0

1.0

—

37.54

—

Juvenile arthritis (FINNGEN)

0.00

0.0

1.0

—

35.36

—

Gluteal tendinitis

0.00

0.0

1.0

—

38.15

—

Pustulosis palmaris et plantaris

0.00

0.0

1.0

—

37.06

—

Opening and dilatation of root channel of tooth

0.00

-0.00

0.0

1.0

—

36.00

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS